STAT Plus: 4 questions for neurology startups as venture investors pour millions into the field

As pharmaceutical companies stepped back from developing new drugs for neurological conditions, venture capitalists took a big step forward.

Venture investors have poured more than $500 million into early-stage neurology startups this year, according to a recent health care venture capital report from Silicon Valley Bank — more than six times as much money that was invested in the same over the first six months of last year.

Continue to STAT Plus to read the full story…

Read Original Article: STAT Plus: 4 questions for neurology startups as venture investors pour millions into the field »